ArticleScientific reports2024

A novel T cell-redirecting anti-GPRC5D × CD3 bispecific antibody with potent antitumor activity in multiple myeloma preclinical models.

Urara Tomita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.